Characteristics and management of patients with SARS‐CoV2 infection admitted to pediatric intensive care units: Data analysis of the Spanish national multicenter registry
暂无分享,去创建一个
I. Oulego-Erroz | A. García-Salido | J. C. de Carlos Vicente | S. Belda Hofheinz | C. Guitart Pardellans | B. Huidobro Labarga | M. S. Holanda Peña | María García-Besteiro | C. Rey Galán | C. Calvo Monge | L. Bermúdez Barrezueta | R. G. Cortés | M. Slöcker Barrio | A. Hernández Yuste | S. Sánchiz Cárdenas | A. Jiménez Olmos | D. Roca Pascual | Maite Cuervas-Mons Tejedor | E. Morteruel Arizcuren | M. Rodríguez Rubio | C. Martínez Padilla | P. González Navarro | A. García‐Salido
[1] A. Randolph,et al. Treatment of Multisystem Inflammatory Syndrome in Children: Understanding Differences in Results of Comparative Effectiveness Studies , 2022, ACR open rheumatology.
[2] Bryant J. Webber,et al. Characteristics and Clinical Outcomes of Children and Adolescents Aged <18 Years Hospitalized with COVID-19 — Six Hospitals, United States, July–August 2021 , 2021, MMWR. Morbidity and mortality weekly report.
[3] E. Liu,et al. Potentially effective drugs for the treatment of COVID-19 or MIS-C in children: a systematic review , 2021, European Journal of Pediatrics.
[4] J. Meek,et al. Risk Factors for Severe COVID-19 in Children. , 2021, Pediatrics.
[5] Manish M Patel,et al. Effectiveness of Pfizer-BioNTech mRNA Vaccination Against COVID-19 Hospitalization Among Persons Aged 12–18 Years — United States, June–September 2021 , 2021, MMWR. Morbidity and mortality weekly report.
[6] Manish M Patel,et al. Incidence of Multisystem Inflammatory Syndrome in Children Among US Persons Infected With SARS-CoV-2 , 2021, JAMA network open.
[7] A. Chokkalingam,et al. Compassionate Use of Remdesivir in Children With Severe COVID-19 , 2021, Pediatrics.
[8] Manish M Patel,et al. Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19. , 2021, JAMA.
[9] A. Belot,et al. Association of Intravenous Immunoglobulins Plus Methylprednisolone vs Immunoglobulins Alone With Course of Fever in Multisystem Inflammatory Syndrome in Children. , 2021, JAMA.
[10] J. Nagaraj,et al. Epidemiology and pathobiology of SARS-CoV-2 (COVID-19) in comparison with SARS, MERS: An updated overview of current knowledge and future perspectives , 2021, Clinical Epidemiology and Global Health.
[11] I. Jordan,et al. Severe manifestations of SARS-CoV-2 in children and adolescents: from COVID-19 pneumonia to multisystem inflammatory syndrome: a multicentre study in pediatric intensive care units in Spain , 2020, Critical Care.
[12] S. Ley,et al. COVID‐19 in childhood: Transmission, clinical presentation, complications and risk factors , 2020, Pediatric pulmonology.
[13] A. García-Salido,et al. Documento español de consenso sobre diagnóstico, estabilización y tratamiento del síndrome inflamatorio multisistémico pediátrico vinculado a SARS-CoV-2 (SIM-PedS) , 2020, Anales de Pediatría.
[14] Sohan Seth,et al. Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study , 2020, BMJ.
[15] I. Bassett,et al. Pediatric Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Clinical Presentation, Infectivity, and Immune Responses , 2020, The Journal of Pediatrics.
[16] M. Antonelli,et al. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy. , 2020, JAMA internal medicine.
[17] I. Jordan,et al. A multicenter national survey of children with SARS-CoV-2 infection admitted to Spanish Pediatric Intensive Care Units , 2020, Intensive Care Medicine.
[18] B. Scholefield,et al. Paediatric Inflammatory Multisystem Syndrome: Temporally Associated with SARS-CoV-2 (PIMS-TS): Cardiac Features, Management and Short-Term Outcomes at a UK Tertiary Paediatric Hospital , 2020, Pediatric Cardiology.
[19] P. Davies,et al. Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2. , 2020, JAMA.
[20] M. Priestley,et al. Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units. , 2020, JAMA pediatrics.
[21] A. Tagarro,et al. Screening and Severity of Coronavirus Disease 2019 (COVID-19) in Children in Madrid, Spain. , 2020, JAMA pediatrics.
[22] R. Jin,et al. Clinical Characteristics of Children with Coronavirus Disease 2019 in Hubei, China , 2020, Current Medical Science.
[23] J. Ramos,et al. Recomendaciones sobre el manejo clínico de la infección por el «nuevo coronavirus» SARS-CoV2. Grupo de trabajo de la Asociación Española de Pediatría (AEP) , 2020, Anales de Pediatría.
[24] OUP accepted manuscript , 2021, Journal of the Pediatric Infectious Diseases Society.
[25] Jérémie F. Cohen,et al. Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study , 2020, BMJ.
[26] Multisystem In fl ammatory Syndrome in Children: An International Survey , 2022 .